Actively Recruiting
Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery
Led by Aydin Adnan Menderes University · Updated on 2026-03-04
40
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective, randomized, single-center, study aims to evaluate the postoperative analgesic effectiveness of bilateral Rhomboid Intercostal Block (RIB) in patients undergoing elective bilateral breast prosthesis surgery. Effective postoperative pain management is essential to improve patient comfort and reduce opioid consumption. Eligible patients aged 18-65 years with ASA physical status I-II will be randomly assigned to either receive ultrasound-guided bilateral RIB block in addition to standard general anesthesia or undergo surgery without any regional block (control group). All patients will receive standardized general anesthesia and postoperative patient-controlled analgesia (PCA) with intravenous tramadol. The primary outcome of the study is total tramadol consumption within the first 24 postoperative hours. Secondary outcomes include postoperative pain scores at predefined time points, time to first analgesic requirement, need for rescue analgesia, incidence of nausea and vomiting, and block-related complications. The results of this study will help determine whether bilateral RIB block provides superior postoperative pain control compared to standard analgesic management alone in bilateral breast prosthesis surgery.
CONDITIONS
Official Title
Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18-65 years
- American Society of Anesthesiologists (ASA) physical status I-II
- Scheduled for elective bilateral breast prosthesis surgery
- Ability to understand the study protocol and provide written informed consent
You will not qualify if you...
- Refusal to participate
- Known allergy or hypersensitivity to lidocaine, bupivacaine, or tramadol
- Coagulation disorders or current anticoagulant therapy
- Infection at the injection site
- Chronic opioid use or chronic pain syndromes
- Severe hepatic, renal, or cardiac disease
- Neurological or psychiatric conditions interfering with pain assessment
- Body mass index (BMI) > 35 kg/m�b2
- Pregnancy or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Aydın Adnan Menderes University Hospital, Department of Anesthesiology and Reanimation
Aydin, Efeler, Turkey (Türkiye), 09010
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here